4391 – 4400 of 7628
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Pancreatic cancer - cost for overtreatment with gemcitabine.
(
- Contribution to journal › Article
-
Mark
Time trends in survival from cancer of unknown primary: Small steps forward.
(
- Contribution to journal › Article
-
Mark
Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort
(
- Contribution to journal › Article
-
Mark
Low expression of SHP-2 is associated with less favorable prostate cancer outcomes.
(
- Contribution to journal › Article
-
Mark
Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.
(
- Contribution to journal › Scientific review
-
Mark
Detecting EGFR alterations in clinical specimens-pitfalls and necessities.
(
- Contribution to journal › Article
-
Mark
Mutation spectrum in South American Lynch syndrome families
(
- Contribution to journal › Article
-
Mark
Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration.
(
- Contribution to journal › Article
-
Mark
A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Site-specific survival rates for cancer of unknown primary (CUP) according to location of metastases.
(
- Contribution to journal › Article